Doris Quinkert

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Journal: Immunity
Published: January 27, 2026

Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infection.

Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infection.

Journal: Cell reports
Published: September 19, 2025

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Journal: EMBO molecular medicine
Published: June 21, 2025

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Journal: Nature communications
Published: June 20, 2025

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.

Journal: EMBO molecular medicine
Published: March 25, 2024

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Journal: Vaccine
Published: March 01, 2024

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.

Journal: Nature communications
Published: February 20, 2024

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

Journal: Cell reports. Medicine
Published: January 05, 2024

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions.

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions.

Journal: Malaria journal
Published: December 07, 2023

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

Journal: Cell
Published: September 28, 2023

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.

Journal: PLoS pathogens
Published: February 02, 2023

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Journal: Frontiers in immunology
Published: July 01, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026